NRIX - Nurix Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NRIX is currently covered by 11 analysts with an average price target of $28.43. This is a potential upside of $11.56 (68.52%) from yesterday's end of day stock price of $16.87.

Nurix Therapeutics 's activity chart (see below) currently has 56 price targets and 87 ratings on display. The stock rating distribution of NRIX is 94.44% BUY and 5.56% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.4% with an average time for these price targets to be met of 187.27 days.

Highest price target for NRIX is $36, Lowest price target is $17, average price target is $28.43.

Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 03-Feb-2025. First documented stock forecast 18-Aug-2020.

Currently out of the existing stock ratings of NRIX, 51 are a BUY (94.44%), 3 are a HOLD (5.56%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$17

$0.13 (0.77%)

$10

19 days ago
(03-Feb-2025)

3/4 (75%)

$-1.95 (-10.29%)

81

Buy

$36

$19.13 (113.40%)

$30

24 days ago
(29-Jan-2025)

2/11 (18.18%)

$16.35 (83.21%)

103

Buy

$30

$13.13 (77.83%)

$34

24 days ago
(29-Jan-2025)

2/8 (25%)

$10.35 (52.67%)

64

Buy

$28

$11.13 (65.98%)

$29

24 days ago
(29-Jan-2025)

0/22 (0%)

$8.35 (42.49%)

Buy

$36

$19.13 (113.40%)

$35

24 days ago
(29-Jan-2025)

2/12 (16.67%)

$16.35 (83.21%)

125

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NRIX (Nurix Therapeutics ) average time for price targets to be met?

On average it took 187.27 days on average for the stock forecasts to be realized with a an average price target met ratio 40.4

Which analyst has the current highest performing score on NRIX (Nurix Therapeutics ) with a proven track record?

DEREK ARCHILA

Which analyst has the most public recommendations on NRIX (Nurix Therapeutics )?

Derek Archila works at WELLS FARGO and has 5 price targets and 3 ratings on NRIX

Which analyst is the currently most bullish on NRIX (Nurix Therapeutics )?

Tyler Van Buren with highest potential upside - $52.14

Which analyst is the currently most reserved on NRIX (Nurix Therapeutics )?

Christopher Liu with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?